ASPIC

send to a friend share this

8th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

Grand hotel Huis der Tuin, Noordwijk, the Netherlands

 

21 - 23 June, 2015

 

See more informations here: http://focaltherapy.org/

13th Annual Meeting of the Association for Cancer Immunotherapy

Rheingoldhalle Congress Center Mainz (CCM), Mainz, Germany

 

11-13 May, 2015

 

See more informations here: http://www.meeting.cimt.eu/

 

 

13th Annual Meeting of the Association for Cancer Immunotherapy

Rheingoldhalle Congress Center Mainz (CCM), Mainz, Germany

 

11-13 May, 2015

 

See more informations here: http://www.meeting.cimt.eu/

 

 

28th Annual Meeting Danish Association for Cancer Research

Vilvorde Kursuscenter, Vilvordevej 70, 2920 Charlottenlund, Denmark

 

30 April, 2015

 

See more informations here: http://www.dscf.dk/AnnualMeetings.htm

28th Annual Meeting Danish Association for Cancer Research

Vilvorde Kursuscenter, Vilvordevej 70, 2920 Charlottenlund, Denmark

 

30 April, 2015

 

See more informations here: http://www.dscf.dk/AnnualMeetings.htm

7th International Conference of Contemporary Oncology

IBB Andersia Hotel, Plac Andersa 3, Poznań, Poland

 

25 - 27 March 2015

 

See more informations here: http://www.termedia.pl/Konferencje?Invitation&e=372&p=2787

7th International Conference of Contemporary Oncology

IBB Andersia Hotel, Plac Andersa 3, Poznań, Poland

 

25 - 27 March 2015

 

See more informations here: http://www.termedia.pl/Konferencje?Invitation&e=372&p=2787

European Human Genetics Conference 2015

SECC, Glasgow, Scotland, United Kingdom

 

6-9 June, 2015

 

See more informations here: https://www.eshg.org/eshg2015.html

European Human Genetics Conference 2015

SECC, Glasgow, Scotland, United Kingdom

 

6-9 June, 2015

 

See more informations here: https://www.eshg.org/eshg2015.html

Identification of a novel germline FOXE1 variant in patients with familial thyroid cancer

The familial forms of non-medullary thyroid carcinoma (FNMTC) represent 5% of thyroid neoplasms. To date, three FNMTC susceptibility genes have been identified (NKX2-1, DICER1 and SRGAP1). This study represents the first evidence of involvement of a germline FOXE1 rare variant in FNMTC etiology. This gene, which encodes the FOXE1 transcription factor involved in the morphogenesis and differentiation of the thyroid, may represent a novel susceptibility gene for this familial thyroid disease.

 

Authors and Affiliations: